Search

Treating Graft vs Host Disease (GvHD) – What can be done when steroids aren’t an option?
Graft vs Host Disease (GvHD) is a common complication for many patients during their recovery after a stem cell transplant. It’s caused by small differences between the new…
Research
Archived
Using donated cells to treat acute Graft vs Host Disease (GvHD)
Jonathan in the Patient Services team discusses recent research into the use of cell therapies to treat Graft versus Host Disease (GvHD), which is a common side effect of stem…
Research
Archived
Three keys to unlock cell therapies faster
Daniel Gibson, Head of Innovation and Commercialisation talks about the advancements in cellular therapy research, and how we are overcoming critical issues in the supply of…
Research
Archived
Fusing blood cells together to treat leukaemia more effectively
Jonathan in our patient services team discusses emerging treatments for cancer, using cell therapy and new ‘super cells’. When developing a new cancer treatment, one of the most…
Research
Archived
Making the perfect match even better for stem cell transplant recipients
After new findings from Anthony Nolan’s Patient/Donor project have been published, Jonathan from our Patient Services team looks at how new technology is helping us understand…
Research
Archived
How patients’ views helped inform the approval of a new CMV reactivation drug in Scotland
After the news that the Scottish Medicine Consortium has recommended letermovir (Prevymis) for routine use on the NHS in Scotland, Bradley from our Policy and Public Affairs team…
Research
Archived
Education: the key to transforming young people’s understanding of stem cell donation
Young people have a very mixed understanding of what stem cell donation involves. In this blog, Anthony Nolan’s Chief Executive Henny Braund explains how new guidelines from the…
Research
Archived
Cord blood – not just an alternative
Daniel Gibson, Anthony Nolan’s Assistant Director of the Cell and Gene Therapy Service, talks about the enormous potential of cord blood as a starting material in research to help…
Research
Archived
Do you know your donor?
Daniel Gibson, Anthony Nolan’s Assistant Director of the Cell and Gene Therapy Service, talks about the importance of where starting materials come from and how the Anthony Nolan…
Research
Archived
Are cells the new pills for patients?
With new breakthroughs in cell therapies, Dr Diana Hernandez, Senior Research Scientist and Immunotherapy Group Leader at Anthony Nolan, explains the science behind these…
Research
Archived